News / New publications

Research

We work together for a better translational approach, from basic to clinical science

  • Read more

Core facilities

Our advanced core facilities offer excellent opportunities

  • Read more

Recruitment

We welcome the best research talents from Norway and the rest of the world

  • Read more

Archives IEMR

  • Publications
  • News archive
  • Visual profile

About IEMR

  • About
  • Funding
  • Collaborations
  • Staff

Contact IEMR

  • Contact
  • Group leaders
  • Leadership
  • Safety representative (VO)

Signaling protein Syndecan-4 reveals new knowledge of the female heart

Støle TP, Lunde M, Shen X, Martinsen M, Lunde PK, Li J, Lockwood F, Sjaastad I, Louch WE, Aronsen JM, Christensen G, Carlson CR (2022)

The female syndecan-4-/- heart has smaller cardiomyocytes, augmented insulin/pSer473-Akt/pSer9-GSK-3β signaling, and lowered SCOP, pThr308-Akt/Akt and GLUT4 levels

—

 

Sex hormones have been suggested to play an important role in insulin sensitivity. Our results suggest that syndecan-4 may also be involved: We have recently shown that rodents missing syndecan-4 have increased serum insulin levels. Insulin is able to activate a signaling pathway called “Akt”. The Akt signaling pathway is known to promote growth of though fibrous tissue that makes it more difficult for the heart to beat, and increases the size of the heart cells causing the heart to become bigger than it should. However, an elevation in Akt signaling has been found to be protective for the heart in females due to the female hormone estrogen, whereas the opposite is true for the male heart. Interestingly, we have found that female rodents missing syndecan-4 have an increase in the Akt signaling pathway, but males do not. Various other proteins in the Akt network, involved in insulin-Akt signaling, such as GSK-3β and GLUT4, are also altered in the female rodents lacking syndecan-4 (Støle et al., 2022). We are currently investigating how these molecular changes affect hearts lacking syndecan-4 anatomically and functionally. Additionally, we are investigating how the differences we observe between the sexes play a role in the sick heart.

Front Cell Dev Biol, 10, 908126
PubMed 36092718 DOI 10.3389/fcell.2022.908126

Thea Parsberg Støle

Doctoral Research Fellow & Safety representative (VO)

  • View profile

Cathrine Rein Carlson

Group Leader & Senior Researcher

  • View profile

Institute for Experimental Medical Research

Oslo University Hospital, Ullevål

PB 4956 Nydalen

NO-0424 Oslo

Norway

  • Research
  • Core facilities
  • Recruitment
  • Publications
  • News archive
  • Visual profile
  • About
  • Funding
  • Collaborations
  • Staff
  • Contact
  • Group leaders
  • Leadership
  • Safety representative (VO)